This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin._x000D_
_x000D_
_x000D_
Scope of the Report:_x000D_
This report focuses on the Iron Chelation Drug in United States market, to split the market based on manufacturers, states, type and application._x000D_
_x000D_
Market Segment by Manufacturers, this report covers_x000D_
Apotex Inc. (Canada)_x000D_
Cipla (India)_x000D_
Novartis (Switzerland)_x000D_
Sun Pharma (India)_x000D_
Natco Pharma (India)_x000D_
_x000D_
Market Segment by States, covering_x000D_
California_x000D_
Texas_x000D_
New York_x000D_
Florida_x000D_
Illinois_x000D_
_x000D_
Market Segment by Type, covers_x000D_
Deferoxamine_x000D_
Deferiprone_x000D_
Deferasirox_x000D_
_x000D_
Market Segment by Applications, can be divided into_x000D_
Transfusional Iron Overload_x000D_
NTDT Caused Iron Overload_x000D_
_x000D_
There are 17 Chapters to deeply display the United States Iron Chelation Drug market._x000D_
_x000D_
Chapter 1, to describe Iron Chelation Drug Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;_x000D_
_x000D_
Chapter 2, to analyze the manufacturers of Iron Chelation Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;_x000D_
_x000D_
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;_x000D_
_x000D_
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Iron Chelation Drug, for each state, from 2012 to 2017;_x000D_
_x000D_
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;_x000D_
_x000D_
Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;_x000D_
_x000D_
Chapter 12, Iron Chelation Drug market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;_x000D_
_x000D_
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc._x000D_
_x000D_
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);_x000D_
_x000D_
Chapter 15, to describe sales channel, distributors, traders, dealers etc._x000D_
_x000D_
Chapter 16 and 17, to describe Iron Chelation Drug Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents_x000D_
1 Market Overview_x000D_
1.1 Iron Chelation Drug Introduction_x000D_
1.2 Market Analysis by Type_x000D_
1.2.1 Deferoxamine_x000D_
1.2.2 Deferiprone_x000D_
1.2.3 Deferasirox_x000D_
1.3 Market Analysis by Applications_x000D_
1.3.1 Transfusional Iron Overload_x000D_
1.3.2 NTDT Caused Iron Overload_x000D_
1.4 Market Analysis by States_x000D_
1.4.1 California Status and Prospect (2012-2022)_x000D_
1.4.2 Texas Status and Prospect (2012-2022)_x000D_
1.4.3 New York Status and Prospect (2012-2022)_x000D_
1.4.4 Florida Status and Prospect (2012-2022)_x000D_
1.4.5 Illinois Status and Prospect (2012-2022)_x000D_
1.5 Market Dynamics_x000D_
1.5.1 Market Opportunities_x000D_
1.5.2 Market Risk_x000D_
1.5.3 Market Driving Force_x000D_
2 Manufacturers Profiles_x000D_
2.1 Apotex Inc. (Canada)_x000D_
2.1.1 Profile_x000D_
2.1.2 Iron Chelation Drug Type and Applications_x000D_
2.1.2.1 Type 1_x000D_
2.1.2.2 Type 2_x000D_
2.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
2.1.4 Business Overview_x000D_
2.1.5 Apotex Inc. (Canada) News_x000D_
2.2 Cipla (India)_x000D_
2.2.1 Profile_x000D_
2.2.2 Iron Chelation Drug Type and Applications_x000D_
2.2.2.1 Type 1_x000D_
2.2.2.2 Type 2_x000D_
2.2.3 Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
2.2.4 Business Overview_x000D_
2.2.5 Cipla (India) News_x000D_
2.3 Novartis (Switzerland)_x000D_
2.3.1 Profile_x000D_
2.3.2 Iron Chelation Drug Type and Applications_x000D_
2.3.2.1 Type 1_x000D_
2.3.2.2 Type 2_x000D_
2.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
2.3.4 Business Overview_x000D_
2.3.5 Novartis (Switzerland) News_x000D_
2.4 Sun Pharma (India)_x000D_
2.4.1 Profile_x000D_
2.4.2 Iron Chelation Drug Type and Applications_x000D_
2.4.2.1 Type 1_x000D_
2.4.2.2 Type 2_x000D_
2.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
2.4.4 Business Overview_x000D_
2.4.5 Sun Pharma (India) News_x000D_
2.5 Natco Pharma (India)_x000D_
2.5.1 Profile_x000D_
2.5.2 Iron Chelation Drug Type and Applications_x000D_
2.5.2.1 Type 1_x000D_
2.5.2.2 Type 2_x000D_
2.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
2.5.4 Business Overview_x000D_
2.5.5 Natco Pharma (India) News_x000D_
3 United States Iron Chelation Drug Market Competition, by Manufacturer_x000D_
3.1 United States Iron Chelation Drug Sales and Market Share by Manufacturer (2016-2017)_x000D_
3.2 United States Iron Chelation Drug Revenue and Market Share by Manufacturer (2016-2017)_x000D_
3.3 United States Iron Chelation Drug Price by Manufacturers (2016-2017)_x000D_
3.4 Market Concentration Rate_x000D_
3.4.1 Top 3 Iron Chelation Drug Manufacturer Market Share_x000D_
3.4.2 Top 5 Iron Chelation Drug Manufacturer Market Share_x000D_
3.5 Market Competition Trend_x000D_
4 United States Iron Chelation Drug Market Analysis by States_x000D_
4.1 United States Iron Chelation Drug Sales Market Share by States_x000D_
4.2 United States Iron Chelation Drug Sales by States (2012-2017)_x000D_
4.3 United States Iron Chelation Drug Revenue (Value) by States (2012-2017)_x000D_
5 United States Market Segmentation Iron Chelation Drug by Type_x000D_
5.1 United States Iron Chelation Drug Sales, Revenue and Market Share by Type (2012-2017)_x000D_
5.1.1 United States Iron Chelation Drug Sales and Market Share by Type (2012-2017)_x000D_
5.1.2 United States Iron Chelation Drug Revenue and Market Share by Type (2012-2017)_x000D_
5.2 Deferoxamine Sales Growth and Price_x000D_
5.2.1 United States Deferoxamine Sales Growth (2012-2017)_x000D_
5.2.2 United States Deferoxamine Price (2012-2017)_x000D_
5.3 Deferiprone Sales Growth and Price_x000D_
5.3.1 United States Deferiprone Sales Growth (2012-2017)_x000D_
5.3.2 United States Deferiprone Price (2012-2017)_x000D_
5.4 Deferasirox Sales Growth and Price_x000D_
5.4.1 United States Deferasirox Sales Growth (2012-2017)_x000D_
5.4.2 United States Deferasirox Price (2012-2017)_x000D_
6 United States Market Segmentation Iron Chelation Drug by Application_x000D_
6.1 United States Iron Chelation Drug Sales Market Share by Application (2012-2017)_x000D_
6.2 Transfusional Iron Overload Sales Growth (2012-2017)_x000D_
6.3 NTDT Caused Iron Overload Sales Growth (2012-2017)_x000D_
7 California Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers_x000D_
7.1 California Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)_x000D_
7.2 California Iron Chelation Drug Sales and Market Share by Type_x000D_
7.3 California Iron Chelation Drug Sales by Application (2012-2017)_x000D_
8 New York Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers_x000D_
8.1 New York Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)_x000D_
8.2 New York Iron Chelation Drug Sales and Market Share by Type_x000D_
8.3 New York Iron Chelation Drug Sales by Application (2012-2017)_x000D_
9 Texas Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers_x000D_
9.1 Texas Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)_x000D_
9.2 Texas Iron Chelation Drug Sales and Market Share by Type_x000D_
9.3 Texas Iron Chelation Drug Sales by Application (2012-2017)_x000D_
10 Florida Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers_x000D_
10.1 Florida Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)_x000D_
10.2 Florida Iron Chelation Drug Sales and Market Share by Type_x000D_
10.3 Florida Iron Chelation Drug Sales by Application (2012-2017)_x000D_
11 Illinois Iron Chelation Drug Sales, Revenue, by Type, Application and Manufacturers_x000D_
11.1 Illinois Iron Chelation Drug Revenue, Sales and Growth Rate (2012-2017)_x000D_
11.2 Illinois Iron Chelation Drug Sales and Market Share by Type_x000D_
11.3 Illinois Iron Chelation Drug Sales by Application (2012-2017)_x000D_
12 Iron Chelation Drug Market Forecast (2017-2022)_x000D_
12.1 United States Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)_x000D_
12.2 Iron Chelation Drug Market Forecast by States (2017-2022)_x000D_
12.3 Iron Chelation Drug Market Forecast by Type (2017-2022)_x000D_
12.4 Iron Chelation Drug Market Forecast by Application (2017-2022)_x000D_
13 Iron Chelation Drug Manufacturing Cost Analysis_x000D_
13.1 Iron Chelation Drug Key Raw Materials Analysis_x000D_
13.1.1 Key Raw Materials_x000D_
13.1.2 Price Trend of Key Raw Materials_x000D_
13.1.3 Key Suppliers of Raw Materials_x000D_
13.1.4 Market Concentration Rate of Raw Materials_x000D_
13.2 Proportion of Manufacturing Cost Structure_x000D_
13.2.1 Raw Materials_x000D_
13.2.2 Labor Cost_x000D_
13.2.3 Manufacturing Expenses_x000D_
13.3 Manufacturing Process Analysis of Iron Chelation Drug_x000D_
14 Industrial Chain, Sourcing Strategy and Downstream Buyers_x000D_
14.1 Iron Chelation Drug Industrial Chain Analysis_x000D_
14.2 Upstream Raw Materials Sourcing_x000D_
14.3 Raw Materials Sources of Iron Chelation Drug Major Manufacturers in 2016_x000D_
14.4 Downstream Buyers_x000D_
15 Sales Channel, Distributors, Traders and Dealers_x000D_
15.1 Sales Channel_x000D_
15.1.1 Direct Marketing_x000D_
15.1.2 Indirect Marketing_x000D_
15.1.3 Marketing Channel Future Trend_x000D_
15.2 Distributors, Traders and Dealers_x000D_
16 Research Findings and Conclusion_x000D_
17 Appendix_x000D_
17.1 Methodology_x000D_
17.2 Analyst Introduction_x000D_
17.3 Data Source
List of Tables and Figures_x000D_
_x000D_
Figure Iron Chelation Drug Picture_x000D_
Table Product Specifications of Iron Chelation Drug_x000D_
Figure United States Sales Market Share of Iron Chelation Drug by Types in 2016_x000D_
Table Types of Iron Chelation Drug_x000D_
Figure Deferoxamine Picture_x000D_
Table Major Manufacturers of Deferoxamine_x000D_
Figure Deferiprone Picture_x000D_
Table Major Manufacturers of Deferiprone_x000D_
Figure Deferasirox Picture_x000D_
Table Major Manufacturers of Deferasirox_x000D_
Table United States Iron Chelation Drug Sales Market Share by Applications in 2016_x000D_
Table Applications of Iron Chelation Drug_x000D_
Figure Transfusional Iron Overload Picture_x000D_
Figure NTDT Caused Iron Overload Picture_x000D_
Figure California Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)_x000D_
Figure Texas Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)_x000D_
Figure New York Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)_x000D_
Figure Florida Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)_x000D_
Figure Illinois Iron Chelation Drug Revenue (Million USD) and Growth Rate (2012-2022)_x000D_
Table Apotex Inc. (Canada) Basic Information, Manufacturing Base and Competitors_x000D_
Table Apotex Inc. (Canada) Iron Chelation Drug Type and Applications_x000D_
Table Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
Table Cipla (India) Basic Information, Manufacturing Base and Competitors_x000D_
Table Cipla (India) Iron Chelation Drug Type and Applications_x000D_
Table Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
Table Novartis (Switzerland) Basic Information, Manufacturing Base and Competitors_x000D_
Table Novartis (Switzerland) Iron Chelation Drug Type and Applications_x000D_
Table Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
Table Sun Pharma (India) Basic Information, Manufacturing Base and Competitors_x000D_
Table Sun Pharma (India) Iron Chelation Drug Type and Applications_x000D_
Table Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
Table Natco Pharma (India) Basic Information, Manufacturing Base and Competitors_x000D_
Table Natco Pharma (India) Iron Chelation Drug Type and Applications_x000D_
Table Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)_x000D_
Table United States Iron Chelation Drug Sales by Manufacturer (2016-2017)_x000D_
Figure United States Iron Chelation Drug Sales Market Share by Manufacturer in 2016_x000D_
Figure United States Iron Chelation Drug Sales Market Share by Manufacturer in 2017_x000D_
Table United States Iron Chelation Drug Revenue by Manufacturer (2016-2017)_x000D_
Figure United States Iron Chelation Drug Revenue Market Share by Manufacturer in 2015_x000D_
Figure United States Iron Chelation Drug Revenue Market Share by Manufacturer in 2016_x000D_
Table United States Iron Chelation Drug Price by Manufacturers (2016-2017)_x000D_
Figure Top 3 Iron Chelation Drug Manufacturer Market Share in 2016_x000D_
Figure Top 3 Iron Chelation Drug Manufacturer Market Share in 2017_x000D_
Figure Top 5 Iron Chelation Drug Manufacturer Market Share in 2016_x000D_
Figure Top 5 Iron Chelation Drug Manufacturer Market Share in 2017_x000D_
Figure United States Iron Chelation Drug Sales and Growth (2012-2017)_x000D_
Table United States Iron Chelation Drug Sales by States (2012-2017)_x000D_
Table United States Iron Chelation Drug Sales Market Share by States (2012-2017)_x000D_
Figure United States 2012 Iron Chelation Drug Sales Market Share by States_x000D_
Figure United States 2016 Iron Chelation Drug Sales Market Share by States_x000D_
Figure United States Iron Chelation Drug Revenue and Growth (2012-2017)_x000D_
Table United States Iron Chelation Drug Revenue by States (2012-2017)_x000D_
Table United States Iron Chelation Drug Revenue Market Share by States (2012-2017)_x000D_
Table United States 2012 Iron Chelation Drug Revenue Market Share by States_x000D_
Table United States 2016 Iron Chelation Drug Revenue Market Share by States_x000D_
Table United States Iron Chelation Drug Sales by Type (2012-2017)_x000D_
Table United States Iron Chelation Drug Sales Share by Type (2012-2017)_x000D_
Table United States Iron Chelation Drug Revenue by Type (2012-2017)_x000D_
Table United States Iron Chelation Drug Revenue Share by Type (2012-2017)_x000D_
Figure United States Deferoxamine Sales Growth (2012-2017)_x000D_
Figure United States Deferoxamine Price (2012-2017)_x000D_
Figure United States Deferiprone Sales Growth (2012-2017)_x000D_
Figure United States Deferiprone Price (2012-2017)_x000D_
Figure United States Deferasirox Sales Growth (2012-2017)_x000D_
Figure United States Deferasirox Price (2012-2017)_x000D_
Table United States Iron Chelation Drug Sales by Application (2012-2017)_x000D_
Table United States Iron Chelation Drug Sales Share by Application (2012-2017)_x000D_
Figure United States Transfusional Iron Overload Sales Growth (2012-2017)_x000D_
Figure United States NTDT Caused Iron Overload Sales Growth (2012-2017)_x000D_
Figure California Iron Chelation Drug Revenue and Growth (2012-2017)_x000D_
Figure California Iron Chelation Drug Sales and Growth (2012-2017)_x000D_
Table California Iron Chelation Drug Sales by Type (2012-2017)_x000D_
Table California Iron Chelation Drug Sales Market Share by Type (2012-2017)_x000D_
Table California Iron Chelation Drug Sales by Application (2012-2017)_x000D_
Table California Iron Chelation Drug Sales Market Share by Application (2012-2017)_x000D_
Figure New York Iron Chelation Drug Revenue and Growth (2012-2017)_x000D_
Figure New York Iron Chelation Drug Sales and Growth (2012-2017)_x000D_
Table New York Iron Chelation Drug Sales by Type (2012-2017)_x000D_
Table New York Iron Chelation Drug Sales Market Share by Type (2012-2017)_x000D_
Table New York Iron Chelation Drug Sales by Application (2012-2017)_x000D_
Table New York Iron Chelation Drug Sales Market Share by Application (2012-2017)_x000D_
Figure Texas Iron Chelation Drug Revenue and Growth (2012-2017)_x000D_
Figure Texas Iron Chelation Drug Sales and Growth (2012-2017)_x000D_
Table Texas Iron Chelation Drug Sales by Type (2012-2017)_x000D_
Table Texas Iron Chelation Drug Sales Market Share by Type (2012-2017)_x000D_
Table Texas Iron Chelation Drug Sales by Application (2012-2017)_x000D_
Table Texas Iron Chelation Drug Sales Market Share by Application (2012-2017)_x000D_
Figure Florida Iron Chelation Drug Revenue and Growth (2012-2017)_x000D_
Figure Florida Iron Chelation Drug Sales and Growth (2012-2017)_x000D_
Table Florida Iron Chelation Drug Sales by Type (2012-2017)_x000D_
Table Florida Iron Chelation Drug Sales Market Share by Type (2012-2017)_x000D_
Table Florida Iron Chelation Drug Sales by Application (2012-2017)_x000D_
Table Florida Iron Chelation Drug Sales Market Share by Application (2012-2017)_x000D_
Figure Illinois Iron Chelation Drug Revenue and Growth (2012-2017)_x000D_
Figure Illinois Iron Chelation Drug Sales and Growth (2012-2017)_x000D_
Table Illinois Iron Chelation Drug Sales by Type (2012-2017)_x000D_
Table Illinois Iron Chelation Drug Sales Market Share by Type (2012-2017)_x000D_
Table Illinois Iron Chelation Drug Sales by Application (2012-2017)_x000D_
Table Illinois Iron Chelation Drug Sales Market Share by Application (2012-2017)_x000D_
Figure United States Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)_x000D_
Table United States Iron Chelation Drug Sales Forecast by States (2017-2022)_x000D_
Table United States Iron Chelation Drug Market Share Forecast by States (2017-2022)_x000D_
Table United States Iron Chelation Drug Sales Forecast by Type (2017-2022)_x000D_
Table United States Iron Chelation Drug Market Share Forecast by Type (2017-2022)_x000D_
Table United States Iron Chelation Drug Sales Forecast by Application (2017-2022)_x000D_
Table United States Iron Chelation Drug Market Share Forecast by Application (2017-2022)_x000D_
Table Sales Base and Market Concentration Rate of Raw Material_x000D_
Figure Price Trend of Key Raw Materials_x000D_
Table Key Suppliers of Raw Materials_x000D_
Figure Manufacturing Cost Structure of Iron Chelation Drug_x000D_
Figure Manufacturing Process Analysis of Iron Chelation Drug_x000D_
Figure Iron Chelation Drug Industrial Chain Analysis_x000D_
Table Raw Materials Sources of Iron Chelation Drug Major Manufacturers in 2016_x000D_
Table Major Buyers of Iron Chelation Drug_x000D_
Table Distributors/Traders/ Dealers List
+1 888 709 8757
Chat With Us